跳至主要内容
临床试验/NL-OMON53630
NL-OMON53630招募中不适用

Integrating biology and behaviour for precision stratification of mental disorders - MENTALPRECISIO

Radboud Universitair Medisch Centrum0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • •Healthy cohort:
  • •- Volunteer aged 16-80, who has participated in prior studies at the Donders
  • •Centre for Cognitive Neuroimaging and for whom neuroimaging data are available
  • •(see protocol for details)
  • •- Has provided consent to be re-contacted for future research
  • •- Possesses and uses an Android smartphone (required for the BeHapp software)
  • •Patient cohort:
  • •- Volunteer who has participated in the MIND-Set 2 study. This means the
  • •subject is:
  • •-- Adult (age >=16) in- and outpatient at the Department of Psychiatry of the
  • •-- Referred for a diagnostic and/or treatment question relating to either
  • •stress-related (mood, anxiety), neurodevelopmental (ASD, ADHD, personality)
  • •and/or impulse-regulation disorders.
  • •These criteria are assessed by the clinician during the intake interview, and
  • •will be confirmed through detailed diagnostic interviews.
  • •- Has provided consent to be contacted about participation in other studies.
  • •- Possesses and uses an Android smartphone (required for the BeHapp software)

排除标准

  • •- Cannot speak, read and/or understand Dutch (VMBO level) and English (working
  • •profiiency)
  • •- Prior history of significant neurological illnesses
  • •- Pregnancy
  • •- Standard contra-indication for MRI:
  • •-- unsafe metal or devices in the body (Cardiac Pacemaker, cochlear implant,
  • •aneurism clip)
  • •-- previous brain surgery
  • •-- moderate to severe claustrophobia
  • •Additional exclusion criteria for healthy controls:
  • •- Current disease that affects the brain
  • •- Prior history of significant psychiatric illness
  • •- Neurological disorders of the central nervous system
  • •- Fifteen or more units of alcohol per week
  • •- Recreational drug use of once or more per week
  • •- Benzodiazepine use of once or more per week
  • •- Malignancies
  • •- Rare, chronic somatic disorders

研究者

相似试验

Unknown
不适用
Development of Systems and Precision Medicine - Take Mood Disorder as an Example.Mood Disorders
NCT04483661National Cheng-Kung University Hospital200
招募中
不适用
Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)Interstitial Lung DiseaseInterstitial Fibrosis
NCT05998512Institut d'Investigació Biomèdica de Bellvitge1,000
招募中
不适用
@neurIST Integrated biomedical informatics for the management of intracranial aneurysmsarterial bulgingarterial widening1000796310002363
NL-OMON30929Erasmus MC, Universitair Medisch Centrum Rotterdam100
进行中(未招募)
1 期
Therapy with BRAF-inhibitor in patients with metastatic melanomaHistologically confirmed cutaneous melanoma that is either Stage IIIc (unresectable) or Stage IV (metastatic), and determined to be BRAF V600 mutation-positiveMedDRA version: 20.0 Level: PT Classification code 10025671 Term: Malignant melanoma stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10025670 Term: Malignant melanoma stage III System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: HLT Classification code 10027156 Term: Skin melanomas (excl ocular) System Organ Class: 100000004858MedDRA version: 20.0 Level: LLT Classification code 10040891 Term: Skin melanoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005569-10-DEniversity Hospital Essen40
已完成
不适用
Effect of wild blueberry intake on reduction of cardiovascular risk factorsRisk factors for cardiovascular diseaseCirculatory System
ISRCTN47732406niversity of Milan (Italy)20